Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

EXACT SCIENCES CORP

EXAS · — · CIK 0001124140 · Healthcare

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

0 Form 4 transaction lines observed in the same window
0 sales · 0 option, withholding, award, gift or other lines

Last qualifying purchase2024-11-13 · Conroy Kevin T · $1.0M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

No Form 4 transaction event is present in the current 180-day window.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-11-13 · Conroy Kevin T.

Recent Form 4 activity

0Purchases
5Sales
120Other Form 4 lines
28SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

The FINRA report lists no short interest for this ticker.

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2024-11-13Conroy Kevin TPurchase (P)Common Stock19,500USD 51.35USD 1,001,325SEC filing ↗

Form 4 evidence

125 transaction lines in the latest 365-day window; 717 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-03-23Zanotti Katherine SD (D)Common Stock60,759USD —USD —SEC filing ↗
2026-03-23Trigg LeslieD (D)Common Stock17,169USD —USD —SEC filing ↗
2026-03-23Popovits Kimberly JD (D)Common Stock16,381USD —USD —SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-03-23Zanotti Katherine SD (D)Common Stock60,759USD —USD —SEC filing ↗
2026-03-23Trigg LeslieD (D)Common Stock17,169USD —USD —SEC filing ↗
2026-03-23Popovits Kimberly JD (D)Common Stock16,381USD —USD —SEC filing ↗
2026-03-23Petrovic ShaceyD (D)Common Stock28,899USD —USD —SEC filing ↗
2026-03-23ORVILLE JACOB AD (D)Common Stock155,500USD —USD —SEC filing ↗
2026-03-23ORVILLE JACOB AAward / grant (A)Common Stock53,323USD 0.00USD 0SEC filing ↗
2026-03-23Herriott JamesD (D)Common Stock69,957USD —USD —SEC filing ↗
2026-03-23Doyle James EdwardD (D)Common Stock57,962USD —USD —SEC filing ↗
2026-03-23Conroy Kevin TD (D)Common Stock1,677,514USD —USD —SEC filing ↗
2026-03-23Conroy Kevin TAward / grant (A)Common Stock119,312USD 0.00USD 0SEC filing ↗
2026-03-23Condella SarahD (D)Common Stock198,259USD —USD —SEC filing ↗
2026-03-23Condella SarahAward / grant (A)Common Stock60,389USD 0.00USD 0SEC filing ↗
2026-03-23Clancy Paul JD (D)Common Stock26,038USD —USD —SEC filing ↗
2026-03-23COWARD D SCOTTD (D)Common Stock62,256USD —USD —SEC filing ↗
2026-03-23Bloomer AaronD (D)Common Stock139,096USD —USD —SEC filing ↗
2026-03-23Bloomer AaronAward / grant (A)Common Stock89,911USD 0.00USD 0SEC filing ↗
2026-03-23Barber Michael JD (D)Common Stock13,136USD —USD —SEC filing ↗
2026-03-23Baranick BrianD (D)Common Stock137,990USD —USD —SEC filing ↗
2026-03-23Baranick BrianAward / grant (A)Common Stock33,321USD 0.00USD 0SEC filing ↗
2026-02-27Conroy Kevin TOption exercise / conversion (M)Common Stock68,097USD 0.00USD 0SEC filing ↗
2026-02-27Conroy Kevin TTax withholding (F)Common Stock32,007USD 103.25USD 3,304,723SEC filing ↗
2026-02-27Condella SarahOption exercise / conversion (M)Common Stock3,900USD 5.03USD 19,617SEC filing ↗
2026-02-27Condella SarahTax withholding (F)Common Stock1,913USD 103.38USD 197,766SEC filing ↗
2026-02-25Conroy Kevin TTax withholding (F)Common Stock6,196USD 103.45USD 640,976SEC filing ↗
2026-02-25Conroy Kevin TAward / grant (A)Common Stock13,181USD 0.00USD 0SEC filing ↗
2025-12-24Baranick BrianTax withholding (F)Common Stock14,938USD 101.59USD 1,517,551SEC filing ↗
2025-12-24Baranick BrianAward / grant (A)Common Stock29,416USD 0.00USD 0SEC filing ↗
2025-12-23ORVILLE JACOB AOption exercise / conversion (M)Common Stock73,080USD 0.00USD 0SEC filing ↗
2025-12-23ORVILLE JACOB ATax withholding (F)Common Stock68,437USD 101.82USD 6,968,255SEC filing ↗
2025-12-23ORVILLE JACOB AAward / grant (A)Common Stock72,523USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerEXAS
CIK0001124140
SectorHealthcare
Industry— Yahoo Finance
SEC SIC8071 Services-Medical Laboratories
Exchange—

Data coverage

Local Form 4 history717 transaction lines from 2020-01-16 to 2026-03-23
1 P purchase lines · 258 S sale lines · 458 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.